These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 668075)

  • 1. Beneficial effects of hydralazine in severe mitral regurgitation.
    Greenberg BH; Massie BM; Brundage BH; Botvinick EH; Parmley WW; Chatterjee K
    Circulation; 1978 Aug; 58(2):273-9. PubMed ID: 668075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of hydralazine in mitral valve prolapse with regurgitation.
    Lin WW; Chang FJ; Hwang JF; Tsai ZH; Lee DY; Chen YT
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Nov; 46(5):259-64. PubMed ID: 2178063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute hemodynamic effects of hydralazine in dogs with chronic mitral regurgitation.
    Kittleson MD; Johnson LE; Oliver NB
    J Am Vet Med Assoc; 1985 Aug; 187(3):258-61. PubMed ID: 4030462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced systemic vascular resistance as therapy for severe mitral regurgitation of valvular origin.
    Harshaw CW; Grossman W; Munro AB; McLaurin LP
    Ann Intern Med; 1975 Sep; 83(3):312-6. PubMed ID: 1180426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral hydralazine on rest and exercise hemodynamics in patients with aortic or mitral regurgitation and left ventricular dysfunction.
    Slosky DA; Hindman MC; Peter RH; Wallace AG
    Clin Cardiol; 1981; 4(4):162-7. PubMed ID: 7273499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for improved cardiac performance with arteriolar dilators in aortic insufficiency.
    Greenberg BH; DeMots H; Murphy E; Rahimtoola SH
    Circulation; 1981 Feb; 63(2):263-8. PubMed ID: 7449051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential hemodynamic and sympathoadrenal effects of sodium nitroprusside and hydralazine in hypertensive subjects.
    Shepherd AM; Irvine NA
    J Cardiovasc Pharmacol; 1986; 8(3):527-33. PubMed ID: 2425168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the vasodilator therapy in regurgitant valvular disease.
    Sasayama S; Ohyagi A; Lee JD; Nonogi H; Sakurai T; Wakabayashi A; Fujita M; Kawai C
    Jpn Circ J; 1982 Apr; 46(4):433-41. PubMed ID: 7087161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nitroglycerin ointment on hemodynamics in patients with mitral insufficiency.
    Gould L; Reddy CV; Zen B; Singh BK
    Angiology; 1980 Oct; 31(10):677-85. PubMed ID: 6778263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine in chronic CHF.
    Chatterjee K; Rouleau JL; Massie BM
    Acta Med Scand Suppl; 1981; 652():99-113. PubMed ID: 6949469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume.
    Miller RR; Vismara LA; DeMaria AN; Salel AF; Mason DT
    Am J Cardiol; 1976 Nov; 38(5):564-7. PubMed ID: 983953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure.
    Rubin LJ; Handel F; Peter RH
    Circulation; 1982 Jun; 65(7):1369-73. PubMed ID: 7074795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
    Franciosa JA; Pierpont G; Cohn JN
    Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison between the hemodynamic effects of hydralazine and nitroglycerin alone and in combination at rest and during isometric exercise in patients with chronic mitral regurgitation.
    Roth A; Shotan A; Elkayam U
    Am Heart J; 1993 Jan; 125(1):155-63. PubMed ID: 8417512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intraoperative nitroprusside unloading in mitral and aortic regurgitation.
    Stone JG; Hoar PF; Faltas AN; Johnson LL; Edie RN; Bowman FO; Malm JR
    J Thorac Cardiovasc Surg; 1979 Jul; 78(1):103-9. PubMed ID: 449373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 17. Favorable effects of hydralazine on the hemodynamic response to isometric exercise in chronic severe aortic regurgitation.
    Elkayam U; McKay CR; Weber L; Eisenberg D; Rahimtoola SH
    Am J Cardiol; 1984 Jun; 53(11):1603-7. PubMed ID: 6731306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Afterload reduction with hydralazine following valve replacement.
    Marco JD; Standeven JW; Barner HB
    J Thorac Cardiovasc Surg; 1980 Jul; 80(1):50-3. PubMed ID: 7382535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves.
    Levine HJ; Gaasch WH
    J Am Coll Cardiol; 1996 Nov; 28(5):1083-91. PubMed ID: 8890799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction.
    Nelson GI; Silke B; Forsyth DR; Verma SP; Hussain M; Taylor SH
    Am J Cardiol; 1983 Nov; 52(8):1036-40. PubMed ID: 6637819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.